Skip to main content

KBC Group NV

Position in NBIX — Neurocrine Biosciences Inc

CIK 1411133 Brussels, C9

Position in NBIX

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$2,241,028
-$2,354,405 QoQ
Shares Held
17,011
-47.5% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

KBC Group NV holds $69,833,201 across 25 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
17,011 $2,241,028

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,241,028 17,011
2025-12-31 $4,595,433 32,401
2025-09-30 $2,044,774 14,566
2025-06-30 $1,830,799 14,566
2025-03-31 $1,530,150 13,835
2024-12-31 $1,956,044 14,330
2024-09-30 $2,185,953 18,972
2024-06-30 $1,464,808 10,640
2024-03-31 $1,446,504 10,488
2023-12-31 $1,394,284 10,582
2023-09-30 $2,120,849 18,852
2023-06-30 $2,973,938 31,537
2023-03-31 $2,849,645 28,153
2022-12-31 $3,459,101 28,961
2022-09-30 $316,718 2,982
2022-06-30 $294,778 3,024
2022-03-31 $266,156 2,839
2021-12-31 $773,173 9,078
2021-09-30 $1,168,279 12,181
2021-06-30 $1,185,454 12,181
2021-03-31 $1,184,602 12,181
2020-12-31 $1,167,548 12,181
2020-09-30 $1,171,324 12,181
2020-06-30 $1,486,082 12,181
2020-03-31 $443,741 5,127